1. |
14Yonemura Y, Endou Y, Kimura K, et al. Inverse expression of S100A4 and Ecadherin is associated with metastatic potential in gastric cancer [J]. Clin Cancer Res, 2000; 6(11)∶4234
15Lee HS, Choi SI, Lee HK, et al. Distinct clinical features and outcomes of gastric cancers with microsatellite instability [J]. Mod Pathol, 2002; 15(6)∶632.
|
2. |
严仲瑜, 万远廉. 消化道肿瘤外科学 [M]. 北京: 北京大学医学出版社, 2003∶194~200.
|
3. |
廖盛日, 陈敏华, 霍苓, 等. 体表超生对胃癌浸润深度的诊断 [J]. 中国超声杂志, 2003; 19(8)∶601.
|
4. |
Akahoshi K, Misawa T, Fujishima H, et al. Regional lymph node metastasis in gastric cancer: evaluation with endoscopic US [J]. Radiology, 1992; 182(2)∶559.
|
5. |
Fukuya T, Honda H, Kaneko K, et al. Efficacy of helical CT in Tstaging of gastric cancer [J]. J Comput Assist Tomogr, 1997; 21(1)∶73.
|
6. |
Chen J, Cheong JH, Yun MJ, et al. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography [J]. Cancer, 2005; 103(11)∶2383.
|
7. |
Lee DH, Ko YT, Park SJ, et al. Comparison of hydroUS and spiral CT in the staging of gastric cancer [J]. Clin Imaging, 2001; 25(3)∶181.
|
8. |
Davies J, Chalmers AG, SueLing HM, et al. Spiral computed tomography and operative staging of gastric carcinoma: a comparison with histopathological staging [J]. Gut, 1997; 41(3)∶314.
|
9. |
Marrelli D, Roviello F, De Stefano A, et al. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection [J]. J Am Coll Surg, 2004; 198(1)∶51.
|
10. |
Takahashi Y, Takeuchi T, Sakamoto J, et al. The usefulness of CEA and/or CA199 in monitoring for recurrence in gastric cancer patients: a prospective clinical study [J]. Gastric Cancer, 2003; 6(3)∶142.
|
11. |
Lai IR,Lee WJ,Huang MT,et al.Comparison of serum CA724,CEA,TPA,CA199 and CA125 levels in gastric cancer patients and correlation with recurrence [J]. Hepatogastroenterology, 2002; 49(46)∶1157.
|
12. |
Sato T, Nishimura G, Nonomura A, et al. Serological studies on CEA, CA 199, STn and SLX in colorectal cancer [J]. Hepatogastroenterology, 1999; 46(26)∶914.
|
13. |
Yonemura Y, Endou Y, Fujita H, et al. Role of MMP7 in the formation of peritoneal dissemination in gastric cancer [J]. Gastric Cancer, 2000; 3(2)∶63.
|
14. |
PintodeSousa J, David L, Reis CA, et al. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinicobiological behaviour of gastric carcinoma [J]. Virchows Arch, 2002; 440(3)∶304.
|